I now have comprehensive material from multiple authoritative textbooks. Let me compile the full answer.
Imaging Findings of Acute Pancreatitis
Sources: Grainger & Allison's Diagnostic Radiology, Yamada's Textbook of Gastroenterology (7e), Harrison's Principles of Internal Medicine (22e), Sleisenger & Fordtran's Gastrointestinal & Liver Disease, Rosen's Emergency Medicine
Diagnostic Criteria for Acute Pancreatitis
Diagnosis requires two of three criteria:
- Typical epigastric pain radiating to the back
- Serum lipase or amylase ≥3× upper limit of normal
- Confirmatory imaging findings on contrast-enhanced CT, MRI, or ultrasound
Imaging is not required when the diagnosis is established by clinical and biochemical criteria alone. - Harrison's Principles of Internal Medicine 22e, p. 2789
1. Plain Abdominal Radiograph
Low yield for diagnosis but may show indirect signs:
| Sign | Significance |
|---|
| Sentinel loop | Localised ileus of proximal jejunum or duodenum adjacent to inflamed pancreas |
| Colon cut-off sign | Spasm of transverse colon at the splenic flexure from spread of inflammation |
| Obscured psoas shadow | Retroperitoneal fluid/inflammation |
| Pancreatic calcification | Suggests underlying chronic pancreatitis |
| Pleural effusion (left > right) | Reactive/sympathetic; correlates with severe disease |
Plain X-ray is useful mainly to exclude other causes (perforated viscus, bowel obstruction) in equivocal presentations.
2. Ultrasound
First-line modality - recommended as initial imaging in ALL patients.
Primary role: evaluate biliary aetiology (gallstones, CBD dilation) and assess for early complications.
Findings
| US Finding | Interpretation |
|---|
| Hypoechoic, heterogeneous, enlarged pancreas | Inflammation/oedema |
| Anechoic peripancreatic fluid | Acute peripancreatic fluid collection |
| Echoes within fluid collection | Suggests necrotic material |
| Gallstones in gallbladder | Biliary aetiology (sensitivity 67-87% in acute setting - reduced by overlying gas/pain-related guarding) |
| Dilated common bile duct | Biliary obstruction - can suggest choledocholithiasis |
| Pancreatic duct dilation | Variable; may suggest obstructive pancreatitis |
Limitations
- Sensitivity for pancreatitis itself is limited - bowel gas and ileus often obscure the pancreas
- Cannot visualise the distal body and tail reliably (retroperitoneal, gas overlay)
- Cannot reliably detect necrosis - this is a critical limitation
- Cannot visualise distal CBD stones reliably in acute setting
Contrast-enhanced ultrasound (CEUS): An alternative to CT when IV contrast is contraindicated (e.g. renal failure). CEUS can delineate necrotic areas (non-enhancing) and is recommended in EFSUMB guidelines for follow-up to reduce repeated CT exposure. - Grainger & Allison's Diagnostic Radiology, p. 681
3. Contrast-Enhanced Computed Tomography (CECT)
The gold standard imaging modality for staging and complications.
When to perform CT
CT is not indicated in all patients on admission:
- Mild pancreatitis with prompt clinical improvement: CT is not required
- CT performed in the first 24 hours may underestimate necrosis (which takes 2-3 days to develop fully)
- Optimal timing: 3-7 days after onset, when necrosis is fully demarcated
- Indications for urgent CT:
- Diagnostic uncertainty
- Failure to improve in 48-72h
- New/persisting organ failure
- Signs of sepsis
- Clinical deterioration
Figure: Appropriate timing of CT - (A) CT at 12h shows minimal pancreatitis; (B) same patient on day 3 shows severe inflammation with fluid collections (Grainger & Allison, p. 681)
CT Protocol
- IV contrast is mandatory - single portal venous phase at 70s (1.5-2 mL/kg at 4 mL/s)
- Arterial phase is not routinely needed unless vascular complication suspected
- Unenhanced images not required routinely
- Radiation dose minimisation is important (young patients may need multiple studies)
CT Findings - Interstitial Oedematous Pancreatitis (IEP)
IEP constitutes 70-80% of all acute pancreatitis cases.
| CT Finding | Description |
|---|
| Pancreatic enlargement | Diffuse or focal; loss of normal lobulated contour |
| Normal or near-normal parenchymal enhancement | Uniform IV contrast uptake (distinguishes IEP from NP) |
| Peripancreatic fat stranding | "Mistiness" or streaky high-attenuation in peripancreatic fat |
| Acute Peripancreatic Fluid Collection (APFC) | Homogeneous fluid density, no wall, confined by fascial planes, immediately adjacent to pancreas; no solid material |
| Thickening of Gerota's fascia | Anterior pararenal space fluid tracking |
| Fluid in omental bursa / lesser sac | Common in pancreatic body/tail inflammation |
| Mild gland heterogeneity | Difficult to differentiate from early necrosis - follow-up CT resolves uncertainty |
Figure: CT of acute interstitial oedematous pancreatitis - severe form with fluid in paracolic gutter and pelvis (Grainger & Allison, p. 682)
CT Findings - Necrotising Pancreatitis (NP)
The single most important CT finding in acute pancreatitis is detection of necrosis, which determines morbidity, mortality, and management. Necrosis develops in 20-30% of patients.
| CT Finding | Description |
|---|
| Focal or diffuse non-enhancement of parenchyma | Defining criterion for necrosis - areas that fail to enhance after IV contrast |
| Liquefaction or severe hypoenhancement | Progressive necrosis of glandular tissue |
| Heterogeneous, phlegmonous retroperitoneum | Severe peri-glandular inflammatory change accompanies significant necrosis |
| Extrapancreatic fat necrosis | "Mass-like" fat-density collections (denser than simple oedema/stranding) |
| Acute Necrotic Collection (ANC) | Heterogeneous collection (fluid + solid necrotic debris); no wall; intra- and/or extrapancreatic |
Three forms of NP (Revised Atlanta):
- Pancreatic + peripancreatic necrosis - most common (75-80%)
- Peripancreatic fat necrosis alone - better prognosis than parenchymal necrosis
- Pancreatic parenchymal necrosis alone - rarest (5%)
Two CT features that correlate with mortality:
- Necrosis of more than one anatomical segment (head, body, or tail)
- Distant fluid collections (posterior pararenal space, paracolic gutter)
Figure: Different morphological types of necrotising pancreatitis on CT (Grainger & Allison, p. 685)
4. CT Severity Scoring Systems
A. Balthazar Grading (Original - 1985)
Grades based on CT appearance of the pancreas and fluid collections:
| Grade | CT Findings | Points |
|---|
| A | Normal pancreas | 0 |
| B | Focal or diffuse enlargement; contour irregularities; no peripancreatic inflammation | 1 |
| C | Grade B + peripancreatic inflammation | 2 |
| D | Grade C + single associated fluid collection | 3 |
| E | Grade C + 2 or more fluid collections, or gas in pancreas/retroperitoneum | 4 |
Prognostic correlation: 5/37 patients (13.5%) with Grade D or E died vs. none of 51 patients with Grades B or C. - Sleisenger & Fordtran, p. 2489
B. CT Severity Index (CTSI) - Balthazar + Necrosis Score
CTSI = Balthazar Grade Points + Necrosis Points
| Degree of Necrosis | Points |
|---|
| None | 0 |
| Up to 33% | 2 |
| 33-50% | 4 |
| >50% | 6 |
Total CTSI score: 0-10
- Local complications developed in 54% of Grade D/E patients vs. 3.9% of Grades A-C
C. Modified CTSI (MCTSI) - Current Preferred
Based on Revised Atlanta Classification - simplified but better outcome correlation:
| Prognostic Indicator | Points |
|---|
| Pancreatic inflammation | |
| Normal pancreas | 0 |
| Intrinsic pancreatic abnormalities ± peripancreatic fat changes | 2 |
| Pancreatic/peripancreatic fluid or fat necrosis | 4 |
| Pancreatic necrosis | |
| None | 0 |
| ≤30% | 2 |
| >30% | 4 |
| Extrapancreatic complications (pleural effusion, ascites, vascular/parenchymal/GI complications) | 2 |
Severity classification:
- Mild: 0-2 points
- Moderate: 4-6 points
- Severe: 8-10 points
- Organ failure incidence: 6% (mild), 9% (moderate), 50% (severe) - Grainger & Allison, p. 681
5. Revised Atlanta Classification - CT Morphological Definitions
The 2012 Revised Atlanta Classification is the current international standard for reporting CT findings in acute pancreatitis:
| Entity | CT Features | Timing |
|---|
| Interstitial pancreatitis | Normal parenchymal enhancement; no peripancreatic necrosis | Early |
| Necrotising pancreatitis | Lack of parenchymal enhancement; and/or peripancreatic necrosis | Early |
| APFC (Acute Peripancreatic Fluid Collection) | Homogeneous fluid density; no wall; no solid component; confined by fascial planes; adjacent to pancreas | <4 weeks after IEP |
| Pancreatic pseudocyst | Well-circumscribed; round/oval; homogeneous fluid density; no solid component; well-defined wall (completely encapsulated); matures >4 weeks after IEP | >4 weeks |
| ANC (Acute Necrotic Collection) | Heterogeneous; liquid + solid density; no definitive wall; intra- and/or extrapancreatic | <4 weeks after NP |
| WON (Walled-Off Necrosis) | Heterogeneous (liquid + solid); well-defined encapsulating wall; intra- and/or extrapancreatic | >4 weeks after NP |
Key distinction for management: Liquid-only collections (APFC, pseudocyst) can be drained; non-liquid collections (ANC, WON) require endoscopic/surgical necrosectomy for the solid component. - Harrison's 22e, p. 2789
Figure: Pancreatic pseudocyst () - well-defined capsule, homogeneous fluid, no solid debris. Coronal (a) and axial (b) reconstruction 6 weeks after acute pancreatitis (Yamada's Gastroenterology, p. 1641)*
Figure: CT of walled-off necrosis () at 5 weeks - heterogeneous content distinguishes it from a pseudocyst (Yamada's Gastroenterology, p. 1642)*
6. MRI and MRCP
MRI
- Excellent alternative to CT when IV contrast is contraindicated (renal failure) or to reduce radiation in young patients
- Superior to CT for: detecting solid debris within collections (distinguishing pseudocyst from WON), detecting pancreatic ductal disruption, and identifying haemorrhage
- T2-weighted sequences: pancreatic oedema appears hyperintense; necrosis is heterogeneous with low T2 areas
- Gadolinium-enhanced sequences: necrosis appears as non-enhancing zones (same principle as CT)
- DWI (diffusion-weighted imaging): restricted diffusion in gangrenous/infected areas
MRCP (Magnetic Resonance Cholangiopancreatography)
- Gold standard non-invasive test for biliary pancreatitis - identifies CBD stones, ductal disruption
- Sensitivity and negative predictive value of 100% for ruling out CBD stones in resolving gallstone pancreatitis - patients with negative MRCP do not need preoperative ERCP - Grainger & Allison, p. 681
- Identifies disconnected pancreatic duct syndrome (duct disruption in necrotising pancreatitis)
- Avoids risks of ERCP (post-ERCP pancreatitis)
Figure: MRCP in biliary pancreatitis - (A) severe pancreatic oedema on T2; (B) large distal CBD stone (arrow) (Grainger & Allison, p. 682)
7. Imaging of Complications
Local Complications
| Complication | CT/Imaging Features |
|---|
| Infected necrosis | Gas bubbles within ANC or WON on CT (highly specific - "mottled gas pattern"); thick-walled; clinical correlation essential |
| Pancreatic abscess | Thick-walled fluid collection (from infected pseudocyst); gas bubbles; occurs in ~3% of severe pancreatitis |
| Pseudoaneurysm | Enhancing arterial structure within or adjacent to pancreatic collection on CECT; splenic artery and gastroduodenal artery most common; confirmed by CT angiography |
| Splenic/portal vein thrombosis | Non-enhancing vein; most common: splenic vein → sinistral (left-sided) portal hypertension |
| Splenic infarction/haemorrhage | Hypoenhancing wedge in spleen; haemoperitoneum |
| Bowel involvement | Wall thickening, oedema of duodenum/transverse colon; necrosis/perforation in severe cases |
| Biliary obstruction | CBD dilation on CT/US; requires MRCP or EUS for stone detection |
Infected necrosis occurs in 20-70% of patients with pancreatic necrosis and is responsible for an estimated 80% of deaths from acute pancreatitis. - Grainger & Allison, p. 683
Systemic Complications on Imaging
| Finding | Modality |
|---|
| Left-sided pleural effusion | CXR/CT - correlates with severity; within 72h predicts severe disease |
| Pulmonary infiltrates/ARDS | CXR - bilateral diffuse infiltrates |
| Ascites | US/CT - free peritoneal fluid |
| Pericardial effusion | Rare; CT/echo |
8. Imaging Algorithm for Clinical Practice
Suspected Acute Pancreatitis
↓
Step 1: Establish diagnosis
→ Abdominal US (all patients, on admission)
- Confirms gallstones/biliary aetiology
- Detects early fluid collections
- LIMITED for pancreatic assessment
↓
Step 2: Clinical assessment 48-72h
→ Mild, improving: NO CT required
→ Equivocal, non-improving, deteriorating:
CECT at 72h-7 days (optimal timing)
↓
Step 3: Complications / Etiology workup
→ Biliary aetiology uncertain: MRCP (or EUS)
→ Suspected infection in necrosis: CECT ± CT-guided FNA
→ Suspected vascular complication: CT angiography
→ Ductal disruption / WON: MRI/MRCP
→ Renal failure (contrast-contraindicated): CEUS or MRI
9. Key Points for Postgraduate Surgery Examination
- Ultrasound first in all patients - primarily to detect biliary aetiology, not to diagnose pancreatitis
- CT is NOT needed on admission in mild, resolving pancreatitis - clinical + biochemical diagnosis suffices
- Optimal CT timing is 3-7 days - necrosis takes 48-72h to fully develop; early CT underestimates severity
- IV contrast is mandatory for CT - without it, necrosis cannot be assessed
- Necrosis = non-enhancing parenchyma on CECT - the critical finding that determines severity
- Balthazar grading A-E + necrosis score = CTSI (0-10) - correlates with local complications better than mortality
- Revised Atlanta 2012 defines 6 morphological entities: IEP, NP, APFC, pseudocyst, ANC, WON
- Key distinction: APFC → pseudocyst (>4wks, IEP); ANC → WON (>4wks, NP)
- WON vs pseudocyst: Both have a wall at >4 weeks, but WON is heterogeneous (solid debris) - MRI/EUS distinguishes them better than CT
- Gas in a collection = infected WON/ANC until proved otherwise
- MRCP NPV of 100% for CBD stones in resolving biliary pancreatitis - negative MRCP avoids ERCP
- Pseudoaneurysm: Splenic artery > gastroduodenal artery; 2-5% incidence; managed by angioembolisation
- Splenic vein thrombosis → sinistral portal hypertension → gastric varices
- Infected necrosis accounts for 80% of deaths from acute pancreatitis
Recent guideline note: The 2026 Ibero-Latin American Guidelines on Acute Pancreatitis (
PMID 42216617) reinforce the Revised Atlanta Classification and confirm CECT as the standard for staging, with MRCP recommended for biliary aetiology evaluation.